Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial

JACC: Cardiovascular Interventions

Volumn 5, Issue 12, 2012, Pages 1231-1238

  Yu, Jennifer ^a,b   Mehran, Roxana ^a,c   Dangas, George D ^a,c   Claessen, Bimmer E ^c   Baber, Usman ^a   Xu, Ke ^c   Parise, Helen ^c   Fahy, Martin ^c   Lansky, Alexandra J ^d   Witzenbichler, Bernhard ^e   Grines, Cindy L ^f   Guagliumi, Giulio ^g   Kornowski, Ran ^h   Wöhrle, Jochen ⁱ   Dudek, Dariusz ^j   Weisz, Giora ^a,k   Stone, Gregg W ^a,k  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DETROIT MEDICAL CENTER   (United States)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF ULM   (Germany)

^h OSPEDALI RIUNITI   (Italy)

ⁱ RABIN MEDICAL CENTER   (Israel)

^j JAGIELLONIAN UNIVERSITY   (Poland)

^k NewYork Presbyterian Hospital   (United States)

more..

Author keywords

acute myocardial infarction; aspirin; bleeding

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG; PACLITAXEL; THIENOPYRIDINE DERIVATIVE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART REINFARCTION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES;

AGED; ASPIRIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; STENTS;

EID: 84871297754     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.07.016     Document Type: Article

References (25)

1. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
2. S. Yusuf, F. Zhao, S.R. Mehta Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
3. S.R. Steinhubl, P.B. Berger, J.T. Mann 3rd CREDO Investigators Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420 (Pubitemid 35340537)
4. The Dutch TIA Trial Study Group A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke N Engl J Med 325 1991 1261 1266
5. S. Derry, Y.K. Loke Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis BMJ 321 2000 1183 1187
6. S.M. Weisman, D.Y. Graham Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events Arch Intern Med 162 2002 2197 2202 (Pubitemid 35231588)
7. S.D. Wiviott, E. Braunwald, C.H. McCabe TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
8. L. Wallentin, R.C. Becker, A. Budaj PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
9. K.W. Mahaffey, D.M. Wojdyla, K. Carroll PLATO Investigators Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial Circulation 124 2011 544 554
10. S.R. Mehta, J.P. Bassand, S. Chrolavicius CURRENT-OASIS 7 Investigators Dose comparisons of clopidogrel and aspirin in acute coronary syndromes N Engl J Med 363 2010 930 942
11. R. Mehran, B. Brodie, D.A. Cox The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial: study design and rationale Am Heart J 156 2008 44 56 (Pubitemid 351862292)
12. G.W. Stone, B. Witzenbichler, G. Guagliumi HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
13. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
14. R.J. Peters, S.R. Mehta, K.A. Fox CURE Trial Investigators Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study Circulation 108 2003 1682 1687 (Pubitemid 37243654)
15. E.J. Topol, D. Easton, R.A. Harrington Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion Trial Investigators Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease Circulation 108 2003 399 406 (Pubitemid 36935531)
16. V.L. Serebruany, S.R. Steinhubl, P.B. Berger Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials Am J Cardiol 95 2005 1218 1222 (Pubitemid 40616424)
17. K.R. McQuaid, L. Laine Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials Am J Med 119 2006 624 638 (Pubitemid 44128438)
18. G.N. Levine, E.R. Bates, J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
19. K.W. Mahaffey, D.M. Wojdyla, K. Carroll PLATO Investigators Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial Circulation 124 2011 544 554
20. F. Van de Werf, D. Ardissino, A. Betriu Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 24 2003 28 66 (Pubitemid 36109547)
21. F. Van de Werf, J. Bax, A. Betriu ESC Committee for Practice Guidelines Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
22. E.M. Antman, D.T. Anbe, P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) J Am Coll Cardiol 44 2004 e1 e211
23. E.M. Antman, M. Hand, P.W. Armstrong 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
24. S.R. Mehta, J.F. Tanguay, J.W. Eikelboom CURRENT-OASIS 7 Trial Investigators Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
25. ® (ticagrelor) efficacy review Slides presented at: FDA Meeting of the Cardiovascular and Renal Drugs Advisory Committee, Adelphi, M.D., July 28, 2010 http://www.fda.gov/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ CardiovascularandRenalDrugsAdvisoryCommittee/ucm221382.htm Accessed October 3, 2011